Cargando…

Hematological Profile Changes Among Oral Contraceptive Users: A Narrative Review

Hematological profiles are measurable indices of blood that can be used to identify and monitor some pathological and physiological abnormalities. Oral contraceptives are one of the factors which may exert an influence on hematological laboratory test results and have a critical importance. Therefor...

Descripción completa

Detalles Bibliográficos
Autores principales: Tekle, Esayas, Gelaw, Yemataw, Asrie, Fikir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528910/
https://www.ncbi.nlm.nih.gov/pubmed/36199529
http://dx.doi.org/10.2147/JBM.S379841
_version_ 1784801390775762944
author Tekle, Esayas
Gelaw, Yemataw
Asrie, Fikir
author_facet Tekle, Esayas
Gelaw, Yemataw
Asrie, Fikir
author_sort Tekle, Esayas
collection PubMed
description Hematological profiles are measurable indices of blood that can be used to identify and monitor some pathological and physiological abnormalities. Oral contraceptives are one of the factors which may exert an influence on hematological laboratory test results and have a critical importance. Therefore, the main goal of this review was to evaluate the hematologic profile alterations brought on by the use of oral contraceptives. Accordingly, even though there were studies that showed no significant difference, most of the oral contraceptive users had higher hemoglobin, platelet, and erythrocyte counts than non-users. Other erythrocyte metrics, such as mean corpuscular volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration and red cell dispersion width, did not significantly change. Moreover, leukocyte count and leukocyte differential count had no significant change among the oral contraceptive users in comparison to non-users. Oral contraceptive users typically have shorter prothrombin times, activated partial thromboplastin times, thrombin times, and greater levels of fibrinogen and D-dimer compared to non-users. However, this review is a narrative review and did not show the pooled effect of oral contraceptives on these hematological parameters. Therefore, it is recommended to do systematic and meta-analysis to determine the pooled effect of oral contraceptives.
format Online
Article
Text
id pubmed-9528910
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-95289102022-10-04 Hematological Profile Changes Among Oral Contraceptive Users: A Narrative Review Tekle, Esayas Gelaw, Yemataw Asrie, Fikir J Blood Med Review Hematological profiles are measurable indices of blood that can be used to identify and monitor some pathological and physiological abnormalities. Oral contraceptives are one of the factors which may exert an influence on hematological laboratory test results and have a critical importance. Therefore, the main goal of this review was to evaluate the hematologic profile alterations brought on by the use of oral contraceptives. Accordingly, even though there were studies that showed no significant difference, most of the oral contraceptive users had higher hemoglobin, platelet, and erythrocyte counts than non-users. Other erythrocyte metrics, such as mean corpuscular volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration and red cell dispersion width, did not significantly change. Moreover, leukocyte count and leukocyte differential count had no significant change among the oral contraceptive users in comparison to non-users. Oral contraceptive users typically have shorter prothrombin times, activated partial thromboplastin times, thrombin times, and greater levels of fibrinogen and D-dimer compared to non-users. However, this review is a narrative review and did not show the pooled effect of oral contraceptives on these hematological parameters. Therefore, it is recommended to do systematic and meta-analysis to determine the pooled effect of oral contraceptives. Dove 2022-09-29 /pmc/articles/PMC9528910/ /pubmed/36199529 http://dx.doi.org/10.2147/JBM.S379841 Text en © 2022 Tekle et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Tekle, Esayas
Gelaw, Yemataw
Asrie, Fikir
Hematological Profile Changes Among Oral Contraceptive Users: A Narrative Review
title Hematological Profile Changes Among Oral Contraceptive Users: A Narrative Review
title_full Hematological Profile Changes Among Oral Contraceptive Users: A Narrative Review
title_fullStr Hematological Profile Changes Among Oral Contraceptive Users: A Narrative Review
title_full_unstemmed Hematological Profile Changes Among Oral Contraceptive Users: A Narrative Review
title_short Hematological Profile Changes Among Oral Contraceptive Users: A Narrative Review
title_sort hematological profile changes among oral contraceptive users: a narrative review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528910/
https://www.ncbi.nlm.nih.gov/pubmed/36199529
http://dx.doi.org/10.2147/JBM.S379841
work_keys_str_mv AT tekleesayas hematologicalprofilechangesamongoralcontraceptiveusersanarrativereview
AT gelawyemataw hematologicalprofilechangesamongoralcontraceptiveusersanarrativereview
AT asriefikir hematologicalprofilechangesamongoralcontraceptiveusersanarrativereview